TGHSA
BCRX icon

TPG Group Holdings (SBS) Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History

TPG Group Holdings (SBS) Advisors’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,162,269
Closed -$12.3M – 38
2014
Q1 		$12.3M Hold
1,162,269
– – 0.13% 20
2013
Q4 		$8.83M Hold
1,162,269
– – 0.11% 20
2013
Q3 		$8.46M Hold
1,162,269
– – 0.11% 14
2013
Q2 		$1.8M Buy
+1,162,269
New +$2M 0.02% 16

Other funds holding BCRX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return

TPG Group Holdings (SBS) Advisors's BCRX Position: Q2 2014 in Review

TPG Group Holdings (SBS) Advisors sold out of BioCryst Pharmaceuticals (BCRX) in Q2 2014, closing a stake of 1,162,269 shares — an estimated $12.3M sold.

TPG Group Holdings (SBS) Advisors first reported a position in BCRX in Q2 2013 and held it in 4 quarters. The position peaked at $12.3M in Q1 2014. 103 funds tracked by Wall St. Rank hold BCRX as of Q2 2014.

  • TPG Group Holdings (SBS) Advisors reported no remaining BioCryst Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • TPG Group Holdings (SBS) Advisors sold 1,162,269 BioCryst Pharmaceuticals shares in Q2 2014, an estimated $12.3M.
  • TPG Group Holdings (SBS) Advisors first reported a position in BioCryst Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • TPG Group Holdings (SBS) Advisors's BioCryst Pharmaceuticals position peaked at $12.3M in Q1 2014.
  • 103 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2014.

Based on TPG Group Holdings (SBS) Advisors's 13F filing for Q2 2014, filed 13 Aug 2014.